Cell Culture History
News and Events
Contact Us
Email Sign Up

Events Calendar

ATCC & Corning Webinar: Genetic Alteration Cell Panels: Effective Tools For High Throughput In Vitro Screening
August 06, 2014
Online , Presenter - David Randle, Ph.D.
Time: 12:00 p.m. - 1:00 p.m.
Additional Information:

Corning and ATCC, two trusted sources for cell culture tools and cells, are pleased to invite you to this upcoming joint webinar. By the end of this webinar, you will learn the advantages of combining Corning® Epic® Technology and the ATCC Molecular Signature Cell Panels for high throughput in vitro screening of key pathways in tumor biology.

Extensive genomic sequencing efforts in recent years have provided detailed profiles of the somatic gene mutations that occur in a wide range of human cancers. In order to facilitate basic and translational cancer research, ATCC has designed and validated a number of genetic alteration cell panels targeting the key molecular pathways identified in these studies. To demonstrate suitability of the panels for high throughput screening, Corning Epic Technology, a label-free platform that uses optical biosensors for high sensitivity biochemical and cell-based assays, was used to evaluate the EGFR panel.
Label-free dynamic mass redistribution (DMR) responses in whole cells provide phenotypic activity profiles which are readily amenable to evaluation of compound activity and pharmacology. DMR responses obtained using the EGFR cell panel showed that Epic Technology can be utilized to evaluate receptor responsiveness to ligands and successfully predict drug response. Furthermore, label-free phenotypic responses can provide profiles of cellular signaling pathways downstream of receptor activation that may identify alternative targets for drug screening in the cell panel. In summary, combining Epic Technology and the EGFR genetic alternation panel offers convenient tools to screen for ligands or biologics that directly target or affect EGFR receptor biology.

Return to Top